Top left to right: Aparna Bhaduri, PhD; Heather Christofk, PhD; Harley Kornblum, PhD; William Zeiger, MD, PhDBottom Left to right: Elizabeth Crouch, PhD; Mohammed Mostajo-Radji, PhD; Carrie Beardon, PhD; Michael Zito, MD As part of our goal of accelerating discoveries and therapies for central nervous system disorders, in 2023, the California Institute for Regenerative Medicine … Continue reading Fueling the Brain: Exploring the connection between metabolism and neurodevelopment
ReMIND
Using Genetic Sequencing and AI to Identify and Treat Schizophrenia
Top left to right: Tomasz Nowakowski, PhD, and Nevan Krogan, PhD Bottom left to right: Aparna Bhaduri, PhD; Matt State, PhD; Alice Ting, PhD; Trey Ideker, PhD; Willow Coyote-Maestas, PhD A UC San Francisco research team funded by the California Institute for Regenerative Medicine (CIRM) is using AI models to explore potential stem cell and … Continue reading Using Genetic Sequencing and AI to Identify and Treat Schizophrenia
How Discovery Research is Unlocking the DNA Behind Psychiatric Disorders
From top left to right: Xin Jin, PhD; Joseph Ecker, PhD; Rusty Gage, PhD Bottom left to right: Eran Mukamel, PhD and Maria Carol Marchetto, PhD As outlined in Proposition 14, one of the goals of the California Institute for Regenerative Medicine (CIRM) is to help accelerate discoveries that enhance our understanding of central nervous … Continue reading How Discovery Research is Unlocking the DNA Behind Psychiatric Disorders
Exploring the Genetic Foundations of Autism and Gene Therapy Treatments
Principal investigator Alex Pollen, PhD, with his co-investigators and team of researchers. A UC San Francisco–led research team, supported by a $12.2 million grant from the California Institute for Regenerative Medicine (CIRM), is exploring how stem cell and gene therapies could help treat neuropsychiatric disorders such as schizophrenia, bipolar disorder, and autism. The project is … Continue reading Exploring the Genetic Foundations of Autism and Gene Therapy Treatments
CIRM Funds new UCSD VERGE Center to Better Understand Schizophrenia and Autism
From top left to right: Anne Bang, PhD; Carrie Bearden, PhD; Eugene Yeo, PhD; Jonathan Sebat, PhD Bottom left to right: Alysson Moutri, PhD; Lilia Iakoucheva, PhD; Sébastien Jacquemont; Trey Ideker, PhD A team of UC San Diego researchers with support of a $12.5 million grant from the California Institute for Regenerative Medicine (CIRM) plans … Continue reading CIRM Funds new UCSD VERGE Center to Better Understand Schizophrenia and Autism
Mental Health Awareness Month: How CIRM is advancing research for neuropsychiatric disorders
Since 1949, Mental Health Awareness Month has been observed in May each year to increase awareness of the importance of mental health and wellness in America. In California, it is estimated that 1.2 million adults have a serious mental illness and that 5.6 million adults have a mental health condition. Today, neuropsychiatric disorders continue to … Continue reading Mental Health Awareness Month: How CIRM is advancing research for neuropsychiatric disorders
Upcoming Funding Opportunity: ReMIND-L Awards
The California Institute for Regenerative Medicine (CIRM) is pleased to announce ReMIND-L, the first funding opportunity under CIRM’s ReMIND Program – a new discovery stage initiative supporting foundational research in the study of neuropsychiatric diseases. Applications are due March 5, 2024 by 2:00 p.m. PST. Applications will be available mid-December 2023 but no later than two months … Continue reading Upcoming Funding Opportunity: ReMIND-L Awards
CIRM approves new plan to invest $110 million into basic research in neuropsychiatric diseases
The California Institute for Regenerative Medicine, the world’s largest institute dedicated to regenerative medicine, announced its approval of a new program called ReMIND at the September Independent Citizens Oversight Committee (ICOC) meeting that will eventually award up to $110 million to advance basic research in neuropsychiatric diseases—one of the largest investments of its kind in … Continue reading CIRM approves new plan to invest $110 million into basic research in neuropsychiatric diseases